Market revenue in 2023 | USD 6,341.0 million |
Market revenue in 2030 | USD 9,029.5 million |
Growth rate | 5.2% (CAGR from 2023 to 2030) |
Largest segment | Api |
Fastest growing segment | API |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | API, Drug Product |
Key market players worldwide | Lonza Group Ltd, Thermo Fisher Scientific Inc, Labcorp Holdings Inc, Catalent Inc, Wuxi AppTec Co Ltd, Siegfried Holding AG, Nipro Corp, Piramal Pharma Solutions, Recipharm Venture Fund, CordenPharma, Cambrex, Bushu Pharmaceuticals, Seqens |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical cdmo market will help companies and investors design strategic landscapes.
Api was the largest segment with a revenue share of 81.18% in 2023. Horizon Databook has segmented the Middle East & Africa pharmaceutical cdmo market based on api, drug product covering the revenue growth of each sub-segment from 2018 to 2030.
Middle Eastern countries such as South Africa, Saudi Arabia, the United Arab Emirates (UAE), and Kuwait are prospering economies. The pharmaceutical CDMO market in the MEA region is likely to grow steadily in the coming years.
The increasing burden of diseases and the demand for drugs are major factors contributing to the growth of the market. Besides, the growing number of clinical trials is anticipated to boost the market growth.
For instance, the WHO International Clinical Trials Registry Platform (ICTRP) reports 861 clinical trials as registered in Africa in 2022. Moreover, less competition between pharmaceutical companies in underdeveloped countries of the region is attracting various pharmaceutical startups.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa pharmaceutical cdmo market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa pharmaceutical cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account